Alexion Pharmaceuticals, Inc.

Slope Name Value S&P500 Average
Revenue USD Million Slope 81.93 1086.04
Gross Margin % Slope -1.76 0.07
Operating Margin % Slope 113.77 0.25
Net Income Million Slope 34.34 107.46
Earnings/share Slope 0.26 -15.28
Dividends USD Slope 0.05
Payout Ratio Slope 1.85
Shares Million Slope 15.53 0.44
Book Value/share Slope 1.15 0.87
Operating Cash Flow Million Slope 36.02 219.87
Free Cash Flow/share Slope 0.54 0.22
Sg&A %/sales Slope -21.15 -0.09
R&D %/sales Slope -104.49 -0.24
Tax Rate Slope 7.63 -0.68
Net Margin Slope 105.32 0.61
Asset Turnover Avg Slope 0.08 -0.0
Return On Assets % Slope 6.32 0.21
Financial Leverage Avg Slope -0.12 1.41
Return On Equity % Slope 10.6 -1.05
Return On Invested Capital % Slope 7.54 0.1
Revenue Growth Yoy Slope -2.5 -1.25
Operating Income Growth Yoy Slope -49.16 -10.55
Net Income Growth Yoy Slope -354.87 -10.41
Cap Ex As %/sales Slope -24.44 -0.12
Free Cf Div By Sales Slope 96.53 0.45
Free Cf Div By Ni Slope 0.02 0.13
Cash Etc % Assets Slope -7.51 0.09
Intangibles % Assets Slope 0.28 0.53
St Debt % Se Plus Liab Slope -0.09 -0.04
Total Current Liabilities % Se Plus Liab Slope 1.27 -0.19
Lt Debt % Se Plus Liab Slope -4.88 0.03
Total Liabilities % Se Plus Liab Slope -4.38 0.21
Quick Ratio Slope -1.67 0.0
Debt To Equity Ratio Slope -0.1 0.25
Price Slope 7.19 1.54
Book Value Million Slope 300.53 620.76
Market Cap Million Slope 1642.96 318.16
Pe Ratio Slope 15.41 -1.62
Pb Ratio Slope -5.52 -0.35
Ps Ratio Slope -1.94 -0.24
Ni Slope Div By Rev Slope 0.0